TY - JOUR AU - Lenihan, D. J. AU - Cardinale, D. M. PY - 2012 DA - 2012// TI - Late cardiac effects of cancer treatment JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2012.45.2938 DO - 10.1200/JCO.2012.45.2938 ID - Lenihan2012 ER - TY - JOUR PY - 2012 DA - 2012// TI - Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up JO - Ann Oncol VL - 23 ID - ref2 ER - TY - JOUR AU - Singal, P. K. AU - Deally, C. M. AU - Weinberg, L. E. PY - 1987 DA - 1987// TI - Subcellular effects of adriamycin in the heart: a concise review JO - J Mol Cell Cardiol VL - 19 UR - https://doi.org/10.1016/S0022-2828(87)80392-9 DO - 10.1016/S0022-2828(87)80392-9 ID - Singal1987 ER - TY - JOUR AU - Simůnek, T. AU - Stérba, M. AU - Popelová, O. AU - Adamcová, M. AU - Hrdina, R. AU - Gersl, V. PY - 2009 DA - 2009// TI - Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron JO - Pharmacol Rep VL - 61 UR - https://doi.org/10.1016/S1734-1140(09)70018-0 DO - 10.1016/S1734-1140(09)70018-0 ID - Simůnek2009 ER - TY - JOUR AU - Bird, B. R. J. H. AU - Swain, S. M. PY - 2008 DA - 2008// TI - Cardiac toxicity in breast cancer survivors: review of potential cardiac problems JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-07-1033 DO - 10.1158/1078-0432.CCR-07-1033 ID - Bird2008 ER - TY - STD TI - National Cancer Institute: Cancer Therapy Evaluation Programm: Common Terminology Criteria for Adverse Events [Internet]. Available from: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_40 UR - http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_40 ID - ref6 ER - TY - JOUR AU - Hoff, D. D. AU - Layard, M. W. AU - Basa, P. AU - Davis, H. L. AU - Hoff, A. L. AU - Rozencweig, M. PY - 1979 DA - 1979// TI - Risk factors for doxorubicin-induced congestive heart failure JO - Ann Intern Med VL - 91 UR - https://doi.org/10.7326/0003-4819-91-5-710 DO - 10.7326/0003-4819-91-5-710 ID - Hoff1979 ER - TY - JOUR AU - Swain, S. M. AU - Whaley, F. S. AU - Ewer, M. S. PY - 2003 DA - 2003// TI - Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials JO - Cancer VL - 97 UR - https://doi.org/10.1002/cncr.11407 DO - 10.1002/cncr.11407 ID - Swain2003 ER - TY - JOUR AU - Legha, S. S. AU - Benjamin, R. S. AU - Mackay, B. AU - Ewer, M. AU - Wallace, S. AU - Valdivieso, M. PY - 1982 DA - 1982// TI - Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion JO - Ann Intern Med VL - 96 UR - https://doi.org/10.7326/0003-4819-96-2-133 DO - 10.7326/0003-4819-96-2-133 ID - Legha1982 ER - TY - JOUR AU - Shapira, J. AU - Gotfried, M. AU - Lishner, M. AU - Ravid, M. PY - 1990 DA - 1990// TI - Reduced cardiotoxicity of doxorubicin by a 6-hour infusion regimen. A prospective randomized evaluation JO - Cancer VL - 65 UR - https://doi.org/3.0.CO;2-D DO - 3.0.CO;2-D ID - Shapira1990 ER - TY - JOUR AU - Danesi, R. AU - Fogli, S. AU - Gennari, A. AU - Conte, P. AU - Tacca, M. PY - 2002 DA - 2002// TI - Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs JO - Clin Pharmacokinet VL - 41 UR - https://doi.org/10.2165/00003088-200241060-00004 DO - 10.2165/00003088-200241060-00004 ID - Danesi2002 ER - TY - JOUR AU - Dalen, E. C. AU - Caron, H. N. AU - Dickinson, H. O. AU - Kremer, L. C. PY - 2011 DA - 2011// TI - Cardioprotective interventions for cancer patients receiving anthracyclines JO - Cochrane Database Syst Rev VL - 6 ID - Dalen2011 ER - TY - JOUR AU - Lipshultz, S. E. AU - Scully, R. E. AU - Lipsitz, S. R. AU - Sallan, S. E. AU - Silverman, L. B. AU - Miller, T. L. PY - 2010 DA - 2010// TI - Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial JO - Lancet Oncol VL - 11 UR - https://doi.org/10.1016/S1470-2045(10)70204-7 DO - 10.1016/S1470-2045(10)70204-7 ID - Lipshultz2010 ER - TY - JOUR AU - Cardinale, D. AU - Colombo, A. AU - Sandri, M. T. AU - Lamantia, G. AU - Colombo, N. AU - Civelli, M. PY - 2006 DA - 2006// TI - Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition JO - Circulation VL - 114 UR - https://doi.org/10.1161/CIRCULATIONAHA.106.635144 DO - 10.1161/CIRCULATIONAHA.106.635144 ID - Cardinale2006 ER - TY - JOUR AU - Bosch, X. AU - Rovira, M. AU - Sitges, M. AU - Domènech, A. AU - Ortiz-Pérez, J. T. AU - Caralt, T. M. PY - 2013 DA - 2013// TI - Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies) JO - J Am Coll Cardiol VL - 61 UR - https://doi.org/10.1016/j.jacc.2013.02.072 DO - 10.1016/j.jacc.2013.02.072 ID - Bosch2013 ER - TY - JOUR AU - Herman, E. H. AU - Ferrans, V. J. PY - 1998 DA - 1998// TI - Preclinical animal models of cardiac protection from anthracycline-induced cardiotoxicity JO - Semin Oncol VL - 25 ID - Herman1998 ER - TY - JOUR AU - Speyer, J. L. AU - Green, M. D. AU - Kramer, E. AU - Rey, M. AU - Sanger, J. AU - Ward, C. PY - 1988 DA - 1988// TI - Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer JO - N Engl J Med VL - 319 UR - https://doi.org/10.1056/NEJM198809223191203 DO - 10.1056/NEJM198809223191203 ID - Speyer1988 ER - TY - JOUR AU - Swain, S. M. AU - Whaley, F. S. AU - Gerber, M. C. AU - Weisberg, S. AU - York, M. AU - Spicer, D. PY - 1997 DA - 1997// TI - Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer JO - J Clin Oncol VL - 15 UR - https://doi.org/10.1200/JCO.1997.15.4.1318 DO - 10.1200/JCO.1997.15.4.1318 ID - Swain1997 ER - TY - JOUR AU - Tebbi, C. K. AU - London, W. B. AU - Friedman, D. AU - Villaluna, D. AU - Alarcon, P. A. AU - Constine, L. S. PY - 2007 DA - 2007// TI - Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin’s disease JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2005.02.3879 DO - 10.1200/JCO.2005.02.3879 ID - Tebbi2007 ER - TY - JOUR AU - Barry, E. V. AU - Vrooman, L. M. AU - Dahlberg, S. E. AU - Neuberg, D. S. AU - Asselin, B. L. AU - Athale, U. H. PY - 2008 DA - 2008// TI - Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.12.2481 DO - 10.1200/JCO.2007.12.2481 ID - Barry2008 ER - TY - JOUR AU - Vrooman, L. M. AU - Neuberg, D. S. AU - Stevenson, K. E. AU - Asselin, B. L. AU - Athale, U. H. AU - Clavell, L. PY - 2011 DA - 2011// TI - The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium JO - Eur J Cancer VL - 47 UR - https://doi.org/10.1016/j.ejca.2011.03.022 DO - 10.1016/j.ejca.2011.03.022 ID - Vrooman2011 ER - TY - JOUR AU - Hensley, M. L. AU - Hagerty, K. L. AU - Kewalramani, T. AU - Green, D. M. AU - Meropol, N. J. AU - Wasserman, T. H. PY - 2009 DA - 2009// TI - American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.17.2627 DO - 10.1200/JCO.2008.17.2627 ID - Hensley2009 ER - TY - JOUR AU - Wexler, L. H. AU - Andrich, M. P. AU - Venzon, D. AU - Berg, S. L. AU - Weaver-McClure, L. AU - Chen, C. C. PY - 1996 DA - 1996// TI - Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin JO - J Clin Oncol VL - 14 UR - https://doi.org/10.1200/JCO.1996.14.2.362 DO - 10.1200/JCO.1996.14.2.362 ID - Wexler1996 ER - TY - JOUR AU - Lopez, M. AU - Vici, P. AU - Lauro, K. AU - Conti, F. AU - Paoletti, G. AU - Ferraironi, A. PY - 1998 DA - 1998// TI - Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas JO - J Clin Oncol VL - 16 UR - https://doi.org/10.1200/JCO.1998.16.1.86 DO - 10.1200/JCO.1998.16.1.86 ID - Lopez1998 ER - TY - JOUR AU - Schiavetti, A. AU - Castello, M. A. AU - Versacci, P. AU - Varrasso, G. AU - Padula, A. AU - Ventriglia, F. PY - 1997 DA - 1997// TI - Use of ICRF-187 for prevention of anthracycline cardiotoxicity in children: preliminary results JO - Pediatr Hematol Oncol VL - 14 UR - https://doi.org/10.3109/08880019709009491 DO - 10.3109/08880019709009491 ID - Schiavetti1997 ER - TY - JOUR AU - Bu’Lock, F. A. AU - Gabriel, H. M. AU - Oakhill, A. AU - Mott, M. G. AU - Martin, R. P. PY - 1993 DA - 1993// TI - Cardioprotection by ICRF187 against high dose anthracycline toxicity in children with malignant disease JO - Br Heart J VL - 70 UR - https://doi.org/10.1136/hrt.70.2.185 DO - 10.1136/hrt.70.2.185 ID - Bu’Lock1993 ER - TY - JOUR AU - Matos Neto, R. P. AU - Petrilli, A. S. AU - Silva, C. M. C. AU - Campos Filho, O. AU - Oporto, V. M. AU - FG, G. L. PY - 2006 DA - 2006// TI - Left ventricular systolic function assessed by echocardiography in children and adolescents with osteosarcoma treated with doxorubicin alone or in combination with dexrazoxane JO - Arq Bras Cardiol VL - 87 UR - https://doi.org/10.1590/S0066-782X2006001900013 DO - 10.1590/S0066-782X2006001900013 ID - Matos Neto2006 ER - TY - JOUR AU - Paiva, M. G. AU - Petrilli, A. S. AU - Moisés, V. A. AU - Macedo, C. R. D. AU - Tanaka, C. AU - Campos, O. PY - 2005 DA - 2005// TI - Cardioprotective effect of dexrazoxane during treatment with doxorubicin: a study using low-dose dobutamine stress echocardiography JO - Pediatr Blood Cancer VL - 45 UR - https://doi.org/10.1002/pbc.20488 DO - 10.1002/pbc.20488 ID - Paiva2005 ER - TY - JOUR AU - Chow, W. A. AU - Synold, T. W. AU - Tetef, M. L. AU - Longmate, J. AU - Frankel, P. AU - Lawrence, J. PY - 2004 DA - 2004// TI - Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies JO - Cancer Chemother Pharmacol VL - 54 UR - https://doi.org/10.1007/s00280-004-0803-4 DO - 10.1007/s00280-004-0803-4 ID - Chow2004 ER - TY - JOUR AU - Eisenhauer, E. A. AU - Therasse, P. AU - Bogaerts, J. AU - Schwartz, L. H. AU - Sargent, D. AU - Ford, R. PY - 2009 DA - 2009// TI - New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2008.10.026 DO - 10.1016/j.ejca.2008.10.026 ID - Eisenhauer2009 ER - TY - JOUR AU - Cesne, A. AU - Yovine, A. AU - Blay, J. -. Y. AU - Delaloge, S. AU - Maki, R. G. AU - Misset, J. -. L. PY - 2012 DA - 2012// TI - A retrospective pooled analysis of trabectedin safety in 1,132 patients with solid tumors treated in phase II clinical trials JO - Invest New Drugs VL - 30 UR - https://doi.org/10.1007/s10637-011-9662-0 DO - 10.1007/s10637-011-9662-0 ID - Cesne2012 ER -